Articles scientifiques 2021

Déc 31, 2021 | Articles dans des revues à comité de lecture

Bistoquet M., Makinson A., Tribout V., Perrollaz C., Bourrel G., Reynes J., et Oude Engberink A.,
Pre-exposure prophylaxis makes it possible to better live one’s sexuality and guide men who have sex with men towards a responsible approach to their health: a phenomenological qualitative study about primary motivations for PrEP,
AIDS Res Ther, vol. 18, no 1, p. 2, janv. 2021. doi: 10.1186/s12981-020-00327-7.

Villerabel C., Makinson A., Jaussent A., Picot M.-C., Nègre-Pagès L., Rouvière J.-A., Favier V., Crampette L., Morquin D., Reynes J., Le Moing V., Tuaillon E., et Venail F.,
Diagnostic Value of Patient-Reported and Clinically Tested Olfactory Dysfunction in a Population Screened for COVID-19,
JAMA Otolaryngol Head Neck Surg, janv. 2021. doi: 10.1001/jamaoto.2020.5074.

Bellet V., Kassi F. K., Krasteva D., Roger F., Drakulovski P., Mossou C., Kouakou G. A., Doumbia A., Delaporte E., Menan H., et Bertout S.,
First report of cryptococcosis due to Cryptococcus gattii sensu stricto VGI in an Ivorian HIV negative patient,
J Mycol Med, vol. 31, no 2, p. 101113, janv. 2021. doi: 10.1016/j.mycmed.2021.101113.

Raulino R., Thaurignac G., Butel C., Villabona-Arenas C. J., Foe T., Loul S., Ndimbo-Kumugo S.-P., Mbala-Kingebeni P., Makiala-Mandanda S., Ahuka-Mundeke S., Kerkhof K., Delaporte E., Ariën K. K., Foulongne V., Mpoudi Ngole E., Peeters M., et Ayouba A.,
Multiplex detection of antibodies to Chikungunya, O’nyong-nyong, Zika, Dengue, West Nile and Usutu viruses in diverse non-human primate species from Cameroon and the Democratic Republic of Congo,
PLoS Negl Trop Dis, vol. 15, no 1, p. e0009028, janv. 2021. doi: 10.1371/journal.pntd.0009028.

Rouveau N., Ky-Zerbo O., Boye S., Fotso A. S., d’Elbée M., Maheu-Giroux M., Silhol R., Kouassi A. K., Vautier A., Doumenc-Aïdara C., Breton G., Keita A., Ehui E., Ndour C. T., Boilly M.-C., Terris-Prestholt F., Pourette D., Desclaux A., Larmarange J., et ATLAS Team,
Describing, analysing and understanding the effects of the introduction of HIV self-testing in West Africa through the ATLAS programme in Côte d’Ivoire, Mali and Senegal,
BMC Public Health, vol. 21, no 1, p. 181, janv. 2021. doi: 10.1186/s12889-021-10212-1.

Bihan C. L., Faucherre V., Moing V. L., Mehenni A., Nantes D., Silva A. D., Jaume C., Lassalle F., et Makinson A.,
COVID-19: The Forgotten Cases of Hidden Exiles,
Infect Dis Now, janv. 2021. doi: 10.1016/j.idnow.2021.01.008.

Yaya I, Dembélé Keita B, Anoma C, Dah TTE, Mensah E, Spire B, Laurent C; CohMSM Study Group. Low seroprevalence of hepatitis C among men who have sex with men in West Africa. Clin Infect Dis 2021 Aug 2; 73(3):e858-9. doi: 10.1093/cid/ciab064. 

Collonnaz M., Erpelding M.-L., Alla F., Goehringer F., Delahaye F., Iung B., Le Moing V., Hoen B., Selton-Suty C., Agrinier N., et AEPEI Study Group,
Impact of referral bias on prognostic studies outcomes: insights from a population-based cohort study on infective endocarditis,
Ann Epidemiol, vol. 54, p. 29‑37, févr. 2021. doi: 10.1016/j.annepidem.2020.09.008.

Veyrenche N., Bolloré K., Pisoni A., Bedin A.-S., Mondain A.-M., Ducos J., Segondy M., Montes B., Pastor P., Morquin D., Makinson A., Le Moing V., Van de Perre P., Foulongne V., et Tuaillon E.,
Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission,
J Med Virol, févr. 2021. doi: 10.1002/jmv.26855.

Bousquet J., Czarlewski W., Zuberbier T., Mullol J., Blain H., Cristol J.-P., De La Torre R., Pizarro Lozano N., Le Moing V., Bedbrook A., Agache I., Akdis C. A., Canonica G. W., Cruz A. A., Fiocchi A., Fonseca J. A., Fonseca S., Gemicioğlu B., Haahtela T., Iaccarino G., Ivancevich J. C., Jutel M., Klimek L., Kraxner H., Kuna P., Larenas-Linnemann D. E., Martineau A., Melén E., Okamoto Y., Papadopoulos N. G., Pfaar O., Regateiro F. S., Reynes J., Rolland Y., Rouadi P. W., Samolinski B., Sheikh A., Toppila-Salmi S., Valiulis A., Choi H.-J., Kim H. J., et Anto J. M.,
Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19,
Int Arch Allergy Immunol, p. 1‑15, févr. 2021. doi: 10.1159/000514204.

Nkuba Ndaye A., Hoxha A., Madinga J., Mariën J., Peeters M., Leendertz F. H., Ahuka Mundeke S., Ariën K. K., Muyembe Tanfumu J.-J., Mbala Kingebeni P., et Vanlerberghe V.,
Challenges in interpreting SARS-CoV-2 serological results in African countries,
Lancet Glob Health, févr. 2021. doi: 10.1016/S2214-109X(21)00060-7.

Fiorentino M., Sow A., Sagaon-Teyssier L., Mora M., Mengue M.-T., Vidal L., Kuaban C., March L., Laurent C., Spire B., Boyer S., et EVOLCam study Group,
Intimate partner violence by men living with HIV in Cameroon: Prevalence, associated factors and implications for HIV transmission risk (ANRS-12288 EVOLCAM),
PLoS One, vol. 16, no 2, p. e0246192, févr. 2021. doi: 10.1371/journal.pone.0246192.

Yaya I, Boyer V, Ehlan PA, Coulibaly A, Agboyibor MK, Traoré I, Kouamé MJ, Maiga AK, Kotchi OR, Nyasenu YT, Maradan G, Rojas-Castro D, Diallo F, Anoma C, Dah TTE, Mensah E, Dembélé Keita B, Spire B, Dagnra CA, Laurent C; CohMSM Study Group. Heterogeneity in the prevalence of high-risk human papillomavirus infection in human immunodeficiency virus-negative and human immunodeficiency virus-positive men who have sex with men in West Africa. Clin Infect Dis 2021 Dec 16; 73(12):2184-2192. doi: 10.1093/cid/ciab157.

Diallo M. S. K., Toure A., Sow M. S., Kpamou C., Keita A. K., Taverne B., Peeters M., Msellati P., Barry T. A., Etard J.-F., Ecochard R., et Delaporte E.,
Understanding the long-term evolution and predictors of sequelae of Ebola virus disease survivors in Guinea: A 48-month prospective, longitudinal cohort study (PostEboGui),
Clin Infect Dis, févr. 2021. doi: 10.1093/cid/ciab168.

Néant N., Lingas G., Le Hingrat Q., Ghosn J., Engelmann I., Lepiller Q., Gaymard A., Ferré V., Hartard C., Plantier J.-C., Thibault V., Marlet J., Montes B., Bouiller K., Lescure F.-X., Timsit J.-F., Faure E., Poissy J., Chidiac C., Raffi F., Kimmoun A., Etienne M., Richard J.-C., Tattevin P., Garot D., Le Moing V., Bachelet D., Tardivon C., Duval X., Yazdanpanah Y., Mentré F., Laouénan C., Visseaux B., Guedj J., et French COVID Cohort Investigators and French Cohort Study groups,
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort,
Proc Natl Acad Sci U S A, vol. 118, no 8, févr. 2021. doi: 10.1073/pnas.2017962118.

Bedin A.-S., Makinson A., Picot M.-C., Mennechet F., Malergue F., Pisoni A., Nyiramigisha E., Montagnier L., Bollore K., Debiesse S., Morquin D., Veyrenche N., Renault C., Foulongne V., Bret C., Bourdin A., Le Moing V., Van de Perre P., et Tuaillon E.,
Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019,
J Infect Dis, vol. 223, no 4, p. 562‑567, févr. 2021. doi: 10.1093/infdis/jiaa724.

Delaugerre C., Nere M.-L., Eymard-Duvernay S., Armero A., Ciaffi L., Koulla-Shiro S., Sawadogo A., Ngom Gueye N. F., Ndour C. T., Mpoudi Ngolle M., Amara A., Chaix M.-L., et Reynes J.,
Deep sequencing analysis of M184V/I mutation at the switch and at the time of virological failure of boosted protease inhibitor plus lamivudine or boosted protease inhibitor maintenance strategy (substudy of the ANRS-MOBIDIP trial),
J Antimicrob Chemother, févr. 2021. doi: 10.1093/jac/dkab002.

Séverin D., Bessaoud F., Meftah N., Du Thanh A., Tretarre B., Guillot B., et Makinson A.,
A comparative study of classic and HIV-viremic and aviremic AIDS Kaposi sarcoma,
AIDS, vol. 35, no 3, p. 399‑405, mars 2021. doi: 10.1097/QAD.0000000000002744.

Vasiliu A., Eymard-Duvernay S., Tchounga B., Atwine D., de Carvalho E., Ouedraogo S., Kakinda M., Tchendjou P., Turyahabwe S., Kuate A. K., Tiendrebeogo G., Dodd P. J., Graham S. M., Cohn J., Casenghi M., et Bonnet M.,
Community intervention for child tuberculosis active contact investigation and management: study protocol for a parallel cluster randomized controlled trial,
Trials, vol. 22, no 1, p. 180, mars 2021. doi: 10.1186/s13063-021-05124-9.

Taouqi M., Veyri M., Brégigeon S., Pibarot M., Solas C., Makinson A., Marcelin A.-G., Choquet S., Spano J.-P., et Poizot-Martin I.,
Survey on HIV, HBV and HCV screening practices in cancerology,
France,Bull Cancer, mars 2021. doi: 10.1016/j.bulcan.2020.11.019.

Écochard R., Wimba P., Bengehya J., Bianga P. K., Lugwarha S., Oyimangirwe M., Bazeboso J.-A., Tshilolo L., Longo-Mbenza B., Rabilloud M., Iwaz J., Étard J.-F., et Vanhems P.,
The COVID-19 pandemic is deepening the health crisis in South Kivu,
Int J Infect Dis, mars 2021. doi: 10.1016/j.ijid.2021.03.043.

Fiorentino M., Eubanks A., Coulaud P.-J., Couderc C., Keita B. D., Anoma C., Dah E., Mensah E., Maradan G., Bourrelly M., Riegel L., Rojas-Castro D., Yaya I., Spire B., Laurent C., Sagaon-Teyssier L., et CohMSM Study Group,
Homonegativity, sexual violence and condom use with women in men who have sex with men and women in West Africa,
AIDS, vol. 35, no 4, p. 681‑687, mars 2021. doi: 10.1097/QAD.0000000000002782.

Etard J.-F., Touré A., Sow M. S., Subtil F., Camara I., Kpamou C., Delaporte E., et Ecochard R.,
Heterogeneity of contact patterns with Ebola virus disease cases,
J Infect, mars 2021. doi: 10.1016/j.jinf.2021.03.009.

Vessière A., Font H., Gabillard D., Adonis-Koffi L., Borand L., Chabala C., Khosa C., Mavale S., Moh R., Mulenga V., Mwanga-Amumpere J., Taguebue J.-V., Eang M. T., Delacourt C., Seddon J. A., Lounnas M., Godreuil S., Wobudeya E., Bonnet M., et Marcy O.,
Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial,
BMC Pediatr, vol. 21, no 1, p. 136, mars 2021. doi: 10.1186/s12887-021-02576-5.

Gosselin-Grenet A.-S., Almeida R. S. de, Roumagnac P., Ayouba A., Simonin Y., et Nisole S.,
Viruses and scientists under the sun of Montpellier,
Virologie (Montrouge), mars 2021. doi: 10.1684/vir.2021.0885.

Russell R. M., Bibollet-Ruche F., Liu W., Sherrill-Mix S., Li Y., Connell J., Loy D. E., Trimboli S., Smith A. G., Avitto A. N., Gondim M. V. P., Plenderleith L. J., Wetzel K. S., Collman R. G., Ayouba A., Esteban A., Peeters M., Kohler W. J., Miller R. A., François-Souquiere S., Switzer W. M., Hirsch V. M., Marx P. A., Piel A. K., Stewart F. A., Georgiev A. V., Sommer V., Bertolani P., Hart J. A., Hart T. B., Shaw G. M., Sharp P. M., et Hahn B. H.,
CD4 receptor diversity represents an ancient protection mechanism against primate lentiviruses,
Proc Natl Acad Sci U S A, vol. 118, no 13, mars 2021. doi: 10.1073/pnas.2025914118.

Younas M., Psomas C., Reynes C., Cezar R., Kundura L., Portalès P., Merle C., Atoui N., Fernandez C., Le Moing V., Barbuat C., Sotto A., Sabatier R., Winter A., Fabbro P., Vincent T., Reynes J., et Corbeau P.,
Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy,
Front Immunol, vol. 12, p. 663843, mars 2021. doi: 10.3389/fimmu.2021.663843.

Etard J.-F.,
Immunity to Ebola virus: the full picture is being revealed,
The Lancet Infectious Diseases, vol. 21, no 4, p. 441‑442, avr. 2021. doi: 10.1016/S1473-3099(20)30793-3.

Kinganda-Lusamaki E., Black A., Mukadi D. B., Hadfield J., Mbala-Kingebeni P., Pratt C. B., Aziza A., Diagne M. M., White B., Bisento N., Nsunda B., Akonga M., Faye M., Faye O., Edidi-Atani F., Matondo-Kuamfumu M., Mambu-Mbika F., Bulabula J., Di Paola N., Pauthner M. G., Andersen K. G., Palacios G., Delaporte E., Sall A. A., Peeters M., Wiley M. R., Ahuka-Mundeke S., Bedford T., et Tamfum J.-J. M.,
Integration of genomic sequencing into the response to the Ebola virus outbreak in Nord Kivu, Democratic Republic of the Congo,
Nat Med, vol. 27, no 4, p. 710‑716, avr. 2021. doi: 10.1038/s41591-021-01302-z.

Bousquet J., Agache I., Blain H., Jutel M., Ventura M. T., Worm M., Del Giacco S., Benetos A., Bilo M. B., Czarlewski W., Abdul Latiff A. H., Al-Ahmad M., Angier E., Annesi-Maesano I., Atanaskovic-Markovic M., Bachert C., Barbaud A., Bedbrook A., Bennoor K. S., Berghea E. C., Bindslev-Jensen C., Bonini S., Bosnic-Anticevich S., Brockow K., Brussino L., Camargos P., Canonica G. W., Cardona V., Carreiro-Martins P., Carriazo A., Casale T., Caubet J.-C., Cecchi L., Cherubini A., Christoff G., Chu D. K., Cruz A. A., Dokic D., El-Gamal Y., Ebisawa M., Eberlein B., Farrell J., Fernandez-Rivas M., Fokkens W. J., Fonseca J. A., Gao Y., Gavazzi G., Gawlik R., Gelincik A., Gemicioğlu B., Gotua M., Guérin O., Haahtela T., Hoffmann-Sommergruber K., Hoffmann H. J., Hofmann M., Hrubisko M., lenaIllario M., Irani C., Ispayeva Z., Ivancevich J. C., Julge K., Kaidashev I., Khaitov M., Knol E., Kraxner H., Kuna P., Kvedariene V., Lauerma A., Le L. T., Le Moing V., Levin M., Louis R., Lourenco O., Mahler V., Martin F. C., Matucci A., Milenkovic B., Miot S., Montella E., Morais-Almeida M., Mortz C. G., Mullol J., Namazova-Baranova L., Neffen H., Nekam K., Niedoszytko M., Odemyr M., O’Hehir R. E., Okamoto Y., Ollert M., Palomares O., Papadopoulos N. G., Panzner P., Passalacqua G., Patella V., Petrovic M., Pfaar O., Pham-Thi N., Plavec D., Popov T. A., Recto M. T., Regateiro F. S., Reynes J., Roller-Winsberger R. E., Rolland Y., Romano A., Rondon C., Rottem M., Rouadi P. W., Salles N., Samolinski B., Santos A. F., Serpa F. S., Sastre J., Schols J. M. G. A., Scichilone N., Sediva A., Shamji M. H., Sheikh A., Skypala I., Smolinska S., Sokolowska M., Sousa-Pinto B., Sova M., Stelmach R., Sturm G., Suppli Ulrik C., Todo-Bom A. M., Toppila-Salmi S., Tsiligianni I., Torres M., Untersmayr E., Urrutia Pereira M., Valiulis A., Vitte J., Vultaggio A., Wallace D., Walusiak-Skorupa J., Wang D.-Y., Waserman S., Yorgancioglu A., Yusuf O. M., Zernotti M., Zidarn M., Chivato T., Akdis C. A., Zuberbier T., et Klimek L.,
Management of anaphylaxis due to COVID-19 vaccines in the elderly,
Allergy, avr. 2021. doi: 10.1111/all.14838.

Campillo J. T., Boussinesq M., Bertout S., Faillie J.-L., et Chesnais C. B.,
Serious adverse reactions associated with ivermectin: A systematic pharmacovigilance study in sub-Saharan Africa and in the rest of the World,
PLoS Negl Trop Dis, vol. 15, no 4, p. e0009354, avr. 2021. doi: 10.1371/journal.pntd.0009354.

Gault N., Esposito-Farèse M., Revest M., Inamo J., Cabié A., Polard É., Hulot J.-S., Ghosn J., Chirouze C., Deconinck L., Diehl J.-L., Poissy J., Epaulard O., Lefèvre B., Piroth L., De Montmollin E., Oziol E., Etienne M., Laouénan C., Rossignol P., Costagliola D., Vidal-Petiot E., et French-Covid cohort investigators, study group,
Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature review,
Fundam Clin Pharmacol, avr. 2021. doi: 10.1111/fcp.12683.

Ndongo F. A., Tejiokem M. C., Penda C. I., Ndiang S. T., Ndongo J.-A., Guemkam G., Sofeu C. L., Tagnouokam-Ngoupo P. A., Kfutwah A., Msellati P., Faye A., et Warszawski J.,
Long-term outcomes of early initiated antiretroviral therapy in sub-Saharan children: a Cameroonian cohort study (ANRS-12140 Pediacam study, 2008-2013, Cameroon),
BMC Pediatr, vol. 21, no 1, p. 189, avr. 2021. doi: 10.1186/s12887-021-02664-6.

Niamsi-Emalio Y., Nana-Djeunga H. C., Chesnais C. B., Pion S. D. S., Tchatchueng-Mbougua J. B., Boussinesq M., Basáñez M.-G., et Kamgno J.,
Unusual localization of blood-borne Loa loa microfilariae in the skin depends on microfilarial density in the blood: Implications for onchocerciasis diagnosis in co-endemic areas,
Clin Infect Dis, avr. 2021. doi: 10.1093/cid/ciab255.

Selinger C., Rahmoun M., Murall C. L., Bernat C., Boué V., Bonneau M., Graf C., Grasset S., Groc S., Reynes J., Hirtz C., Jacobs N., et Alizon S.,
Cytokine response following perturbation of the cervicovaginal milieu during HPV genital infection,
Immunol Res, avr. 2021. doi: 10.1007/s12026-021-09196-2.

Campillo J. T., Chabot E. B., Awaca-Uvon N.-P., Tambwe J.-P., Kuyangisa-Simuna G., Boussinesq M., Chesnais C. B., et Pion S. D.,
Effect of Lymphatic Filariasis and Hookworm Infection on Pregnancy Course and Outcome in Women Living in the Democratic Republic of the Congo,
Am J Trop Med Hyg, mai 2021. doi: 10.4269/ajtmh.20-1422.

Lacroix A., Mbala Kingebeni P., Ndimbo Kumugo S. P., Lempu G., Butel C., Serrano L., Vidal N., Thaurignac G., Esteban A., Mukadi Bamuleka D., Likofata J., Delaporte E., Muyembe Tamfum J.-J., Ayouba A., Peeters M., et Ahuka Mundeke S.,
Investigating the Circulation of Ebola Viruses in Bats during the Ebola Virus Disease Outbreaks in the Equateur and North Kivu Provinces of the Democratic Republic of Congo from 2018,
Pathogens, vol. 10, no 5, mai 2021. doi: 10.3390/pathogens10050557.

Sanogo B., Kiema P. E., Barro M., Nacro S. F., Ouermi S. A., Msellati P., et Nacro B.,
Contribution and Acceptability of Bacteriological Collection Tools in the Diagnosis of Tuberculosis in Children Infected with HIV,
J Trop Pediatr, vol. 67, no 2, mai 2021. doi: 10.1093/tropej/fmab027.

Dah T. T. E., Yaya I., Sagaon-Teyssier L., Coulibaly A., Kouamé M. J.-B., Agboyibor M. K., Maiga K., Traoré I., Mora M., Palvadeau P., Rojas-Castro D., Diallo F., Mensah E., Anoma C., Keita B. D., Spire B., Laurent C., et CohMSM Study Group,
Adherence to quarterly HIV prevention services and its impact on HIV incidence in men who have sex with men in West Africa (CohMSM ANRS 12324 – Expertise France),
BMC Public Health, vol. 21, no 1, p. 972, mai 2021. doi: 10.1186/s12889-021-10994-4.

Ader F., Peiffer-Smadja N., Poissy J., Bouscambert-Duchamp M., Belhadi D., Diallo A., Delmas C., Saillard J., Dechanet A., Mercier N., Dupont A., Alfaiate T., Lescure F.-X., Raffi F., Goehringer F., Kimmoun A., Jaureguiberry S., Reignier J., Nseir S., Danion F., Clere-Jehl R., Bouiller K., Navellou J.-C., Tolsma V., Cabie A., Dubost C., Courjon J., Leroy S., Mootien J., Gaci R., Mourvillier B., Faure E., Pourcher V., Gallien S., Launay O., Lacombe K., Lanoix J.-P., Makinson A., Martin-Blondel G., Bouadma L., Botelho-Nevers E., Gagneux-Brunon A., Epaulard O., Piroth L., Wallet F., Richard J.-C., Reuter J., Staub T., Lina B., Noret M., Andrejak C., Lê M. P., Peytavin G., Hites M., Costagliola D., Yazdanpanah Y., Burdet C., Mentre F., et DisCoVeRy study group,
An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19,
Clin Microbiol Infect, mai 2021. doi: 10.1016/j.cmi.2021.05.020.

Laurent C., Dembélé Keita B., Yaya I., Le Guicher G., Sagaon-Teyssier L., Agboyibor M. K., Coulibaly A., Traoré I., Malan J.-B., De Baetselier I., Eubanks A., Riegel L., Rojas Castro D., Fayé-Ketté H., Koné A., Diandé S., Dagnra C. A., Serrano L., Diallo F., Mensah E., Dah T. T. E., Anoma C., Vuylsteke B., Spire B., et CohMSM-PrEP Study Group,
HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study,
Lancet HIV, mai 2021. doi: 10.1016/S2352-3018(21)00005-9.

Laurent C, Dembélé Keita B, Yaya I, Le Guicher G, Sagaon-Teyssier L, Agboyibor MK, Coulibaly A, Traoré I, Malan JB, De Baetselier I, Eubanks A, Riegel L, Rojas Castro D, Fayé-Ketté H, Koné A, Diandé S, Dagnra CA, Serrano L, Diallo F, Mensah E, Dah TTE, Anoma C, Vuylsteke B, Spire B; CohMSM-PrEP Study Group. HIV pre-exposure prophylaxis for men who have sex with men in West Africa: a multicountry demonstration study. Lancet HIV 2021 July; 8(7):e420-8. doi: 10.1016/S2352-3018(21)00005-9.

De Haas P., Yenew B., Mengesha E., Slyzkyi A., Gashu Z., Lounnas M., Tesfaye E., Bedru A., Tiemersma E., Kremer K., Amare M., Diriba G., Zerihun B., Gudina T., Tegegn B., Bonnet M., Negeri C., et Klinkenberg E.,
The Simple One-Step (SOS) stool processing method for use with the Xpert MTB/RIF assay for a child-friendly diagnosis of tuberculosis closer to the point-of-care,
J Clin Microbiol, p. JCM0040621, juin 2021. doi: 10.1128/JCM.00406-21.

Nkuba A. N., Makiala S. M., Guichet E., Tshiminyi P. M., Bazitama Y. M., Yambayamba M. K., Kazenza B. M., Kabeya T. M., Matungulu E. B., Baketana L. K., Mitongo N. M., Thaurignac G., Leendertz F. H., Vanlerberghe V., Pelloquin R., Etard J.-F., Maman D., Mbala P. K., Ayouba A., Peeters M., Muyembe J.-J. T., Delaporte E., et Ahuka S. M.,
High prevalence of anti-SARS-CoV-2 antibodies after the first wave of COVID-19 in Kinshasa, Democratic Republic of the Congo: results of a cross-sectional household-based survey,
Clin Infect Dis, juin 2021. doi: 10.1093/cid/ciab515.

Wislez M., Domblides C., Greillier L., Mazières J., Monnet I., Kiakouama-Maleka L., Quantin X., Spano J. P., Ricordel C., Fraisse P., Janicot H., Audigier-Valette C., Amour E., Langlais A., Rabbe N., Makinson A., Cadranel J., Laurent-Puig P., Lavolé A., et Blons H.,
Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA),
Lung Cancer, vol. 157, p. 124‑130, juill. 2021. doi: 10.1016/j.lungcan.2021.05.013.

Bousquet J., Czarlewski W., Zuberbier T., Mullol J., Blain H., Cristol J.-P., De La Torre R., Le Moing V., Pizarro Lozano N., Bedbrook A., Agache I., Akdis C. A., Canonica G. W., Cruz A. A., Fiocchi A., Fonseca J. A., Fonseca S., Gemicioğlu B., Haahtela T., Iaccarino G., Ivancevich J. C., Jutel M., Klimek L., Kuna P., Larenas-Linnemann D. E., Melén E., Okamoto Y., Papadopoulos N. G., Pfaar O., Reynes J., Rolland Y., Rouadi P. W., Samolinski B., Sheikh A., Toppila-Salmi S., Valiulis A., Choi H.-J., Kim H. J., et Anto J. M.,
Spices to Control COVID-19 Symptoms: Yes, but Not Only…,
Int Arch Allergy Immunol, vol. 182, no 6, p. 489‑495, 2021. doi: 10.1159/000513538.

Boye S., Bouaré S., Ky-Zerbo O., Rouveau N., Simo Fotso A., d’Elbée M., Silhol R., Maheu-Giroux M., Vautier A., Breton G., Keita A., Bekelynck A., Desclaux A., Larmarange J., et Pourette D.,
Challenges of HIV Self-Test Distribution for Index Testing When HIV Status Disclosure Is Low: Preliminary Results of a Qualitative Study in Bamako (Mali) as Part of the ATLAS Project,
Front Public Health, vol. 9, p. 653543, 2021. doi: 10.3389/fpubh.2021.653543.

Campillo J. T., Awaca-Uvon N. P., Tambwe J.-P., Kuyangisa-Simuna G., Vlaminck J., Weil G. J., Boussinesq M., Chesnais C. B., et Pion S. D. S.,
A strong effect of individual compliance with mass drug administration for lymphatic filariasis on sustained clearance of soil-transmitted helminth infections,
Parasit Vectors, vol. 14, no 1, p. 310, juin 2021. doi: 10.1186/s13071-021-04814-2.

Orikiriza P., Smith J., Ssekyanzi B., Nyehangane D., Mugisha Taremwa I., Turyashemererwa E., Byamukama O., Tusabe T., Ardizzoni E., Marais B. J., Wobudeya E., Kemigisha E., Mwanga-Amumpaire J., Nampijja D., et Bonnet M.,
Tuberculosis diagnostic accuracy of stool Xpert MTB/RIF and urine AlereLAM in vulnerable children,
Eur Respir J, p. 2101116, juin 2021. doi: 10.1183/13993003.01116-2021.

Blok D. J., Kamgno J., Pion S. D., Nana-Djeunga H. C., Niamsi-Emalio Y., Chesnais C. B., Mackenzie C. D., Klion A. D., Fletcher D. A., Nutman T. B., de Vlas S. J., Boussinesq M., et Stolk W. A.,
Feasibility of Onchocerciasis Elimination Using a « Test-and-not-treat » Strategy in Loa loa Co-endemic Areas,
Clin Infect Dis, vol. 72, no 12, p. e1047‑e1055, juin 2021. doi: 10.1093/cid/ciaa1829.

Lavole A., Mazieres J., Schneider S., Brosseau S., Kiakouama L., Greillier L., Guihot A., Abbar B., Baron M., Makinson A., Langlais A., Morin F., Spano J.-P., Cadranel J., et On behalf the French Cooperative Thoracic Intergroup (IFCT),
Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial,
Lung Cancer, vol. 158, p. 146‑150, mai 2021. doi: 10.1016/j.lungcan.2021.05.031.

Roy S., Eiden C., Xatart S., Soler M., Faucherre V., Picot M.-C., Reynes J., Donnadieu-Rigole H., et Peyrière H.,
Bacterial infections in people who inject psychoactive substances: An observational study in a French university hospital,
Therapie, p. S0040-5957(21)00143‑8, juin 2021. doi: 10.1016/j.therap.2021.05.008.

De Castro N., Marcy O., Chazallon C., Messou E., Eholié S., N’takpe J.-B., Bhatt N., Khosa C., Timana Massango I., Laureillard D., Chau G. D., Domergue A., Veloso V., Escada R., Wagner Cardoso S., Delaugerre C., Anglaret X., Molina J.-M., Grinsztejn B., et ANRS 12300 Reflate TB2 study group,
Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial,
Lancet Infect Dis, vol. 21, no 6, p. 813‑822, juin 2021. doi: 10.1016/S1473-3099(20)30869-0.

Taverne B., Laborde-Balen G., Diaw K., Gueye M., Have N.-N., Etard J.-F., et Sow K.,
Does universal health coverage reduce out-of-pocket expenditures for medical consultations for people living with HIV in Senegal? An exploratory cross-sectional study,
BMJ Open, vol. 11, no 7, p. e046579, juill. 2021. doi: 10.1136/bmjopen-2020-046579.

Campillo J. T., Awaca-Uvon N. P., Missamou F., Tambwe J.-P., Kuyangisa-Simuna G., Weil G. J., Louya F., Boussinesq M., Pion S. D. S., et Chesnais C. B.,
Results From 2 Cohort Studies in Central Africa Show That Clearance of Wuchereria bancrofti Infection After Repeated Rounds of Mass Drug Administration With Albendazole Alone Is Closely Linked to Individual Adherence,
Clin Infect Dis, vol. 73, no 1, p. e176‑e183, juill. 2021. doi: 10.1093/cid/ciaa1232.

Lellouche L., Gutierrez L.-A., Leclercq P., Zaegel-Faucher O., Bernard L., Vassallo M., Barbuat C., Ozguler A., Zins M., Nailler L., Reynes J., Berr C., et Makinson A.,
Frailty in Aging People Living With HIV: a matched controlled Study,
J Acquir Immune Defic Syndr, juill. 2021. doi: 10.1097/QAI.0000000000002759.

Vasiliu A., Abelman R. A., Casenghi M., Cohn J., et Bonnet M.,
Symptom-based Screening Versus Chest Radiography for TB Child Contacts: A Systematic Review and Meta-analysis,
Pediatr Infect Dis J, juill. 2021. doi: 10.1097/INF.0000000000003265.

Fiorentino M., Sow A., Sagaon-Teyssier L., Mora M., Mengue M.-T., Vidal L., Kuaban C., March L., Laurent C., Spire B., Boyer S., et EVOLCam study Group,
Intimate partner violence by men living with HIV in Cameroon: Prevalence, associated factors and implications for HIV transmission risk (ANRS-12288 EVOLCAM),
PLoS One, vol. 16, no 2, p. e0246192, 2021. doi: 10.1371/journal.pone.0246192.

Coulaud P.-J., Protopopescu C., Ndiaye K., Baudoin M., Maradan G., Laurent C., Spire B., Vidal L., Kuaban C., Boyer S., et EVOLCam Group,
Individual and healthcare supply-related barriers to treatment initiation in HIV-positive patients enrolled in the Cameroonian antiretroviral treatment access programme,
Health Policy Plan, vol. 36, no 2, p. 137‑148, mars 2021. doi: 10.1093/heapol/czaa153.

Lavole A., Mazieres J., Schneider S., Brosseau S., Kiakouama L., Greillier L., Guihot A., Abbar B., Baron M., Makinson A., Langlais A., Morin F., Spano J.-P., Cadranel J., et On behalf the French Cooperative Thoracic Intergroup (IFCT),
Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial,
Lung Cancer, vol. 158, p. 146‑150, août 2021. doi: 10.1016/j.lungcan.2021.05.031.

Viala B., Villiet M., Redor A., Didelot M.-N., Makinson A., Reynes J., Le Moing V., et Morquin D.,
Using the clinical information system and self-supervision to rationalize the need for antibiotic stewardship: An interventional study in a 2000-bed university hospital,
Int J Antimicrob Agents, vol. 57, no 1, p. 106233, janv. 2021. doi: 10.1016/j.ijantimicag.2020.106233.

Duval X., Le Moing V., Tubiana S., Esposito-Farèse M., Ilic-Habensus E., Leclercq F., Bourdon A., Goehringer F., Selton-Suty C., Chevalier E., Boutoille D., Piriou N., Le Tourneau T., Chirouze C., Seronde M.-F., Morel O., Piroth L., Eicher J.-C., Humbert O., Revest M., Thébault E., Devillers A., Delahaye F., Boibieux A., Grégoire B., Hoen B., Laouenan C., Iung B., Rouzet F., et AEPEI-TEPvENDO study group,
Impact of Systematic Whole-body 18F-Fluorodeoxyglucose PET/CT on the Management of Patients Suspected of Infective Endocarditis: The Prospective Multicenter TEPvENDO Study,
Clin Infect Dis, vol. 73, no 3, p. 393‑403, août 2021. doi: 10.1093/cid/ciaa666.

Elangovan R., Jenks M., Yun J., Dickson-Tetteh L., Kirtley S., Hemelaar J., et WHO-UNAIDS Network for HIV Isolation and Characterisation,
Global and Regional Estimates for Subtype-Specific Therapeutic and Prophylactic HIV-1 Vaccines: A Modeling Study,
Front Microbiol, vol. 12, p. 690647, 2021. doi: 10.3389/fmicb.2021.690647.

Taverne B., Laborde-Balen G., Diaw K., Gueye M., Have N.-N., Etard J.-F., et Sow K.,
Does universal health coverage reduce out-of-pocket expenditures for medical consultations for people living with HIV in Senegal? An exploratory cross-sectional study,
BMJ Open, vol. 11, no 7, p. e046579, juill. 2021. doi: 10.1136/bmjopen-2020-046579.

Dah TTE, Yaya I, Mensah E, Coulibaly A, Kouamé JM, Traoré I, Mora M, Palvadeau P, Anoma C, Keita BD, Spire B, Laurent C; CohMSM Study Group. Rapid antiretroviral therapy initiation and its effect on treatment response in MSM in West Africa. AIDS 2021 Nov 1; 35(13):2201-2210. doi: 10.1097/QAD.0000000000003046.
 

Caby F., Guiguet M., Weiss L., Winston A., Miro J. M., Konopnicki D., Le Moing V., Bonnet F., Reiss P., Mussini C., Poizot-Martin I., Taylor N., Skoutelis A., Meyer L., Goujard C., Bartmeyer B., Boesecke C., Antinori A., Quiros-Roldan E., Wittkop L., Frederiksen C., Castagna A., Thurnheer M. C., Svedhem V., Jose S., Costagliola D., Mary-Krause M., Grabar S., et (CD4/CD8 ratio and cancer risk) project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord,
CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies,
Clin Infect Dis, vol. 73, no 1, p. 50‑59, juill. 2021. doi: 10.1093/cid/ciaa1137.

Campillo J. T., Eiden C., Boussinesq M., Pion S. D. S., Faillie J.-L., et Chesnais C. B.,
Adverse reactions with levamisole vary according to its indications and misuse: a systematic pharmacovigilance study,
Br J Clin Pharmacol, août 2021. doi: 10.1111/bcp.15037.

Blassel L., Tostevin A., Villabona-Arenas C. J., Peeters M., Hué S., Gascuel O., et UK HIV Drug Resistance Database,
Using machine learning and big data to explore the drug resistance landscape in HIV,
PLoS Comput Biol, vol. 17, no 8, p. e1008873, août 2021. doi: 10.1371/journal.pcbi.1008873.

Lee-Cruz L., Lenormand M., Cappelle J., Caron A., De Nys H., Peeters M., Bourgarel M., Roger F., et Tran A.,
Mapping of Ebola virus spillover: Suitability and seasonal variability at the landscape scale,
PLoS Negl Trop Dis, vol. 15, no 8, p. e0009683, août 2021. doi: 10.1371/journal.pntd.0009683.

Makinson A., Park L. S., Stone K., Tate J., Rodriguez-Barradas M. C., Brown S. T., Wadia R., Crothers K., Bedimo R., Goetz M. B., Shebl F., Reynes J., Moing V. L., et Sigel K. M.,
Risks of Opportunistic Infections in People With Human Immunodeficiency Virus With Cancers Treated With Chemotherapy,
Open Forum Infect Dis, vol. 8, no 8, p. ofab389, août 2021. doi: 10.1093/ofid/ofab389.